The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Seung Hyuk Choi; Anand Prasad; Sotirios Tsimikas

doi:10.1016/j.jacc.2008.03.017

The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Seung Hyuk Choi
, Anand Prasad
, Sotirios Tsimikas

Department of Internal Medicine

Sungkyunkwan University
University of California at San Diego

Research output: Contribution to journal › Editorial

15 Scopus citations

Original language	English
Pages (from-to)	2228-2229
Number of pages	2
Journal	Journal of the American College of Cardiology
Volume	51
Issue number	23
DOIs	https://doi.org/10.1016/j.jacc.2008.03.017
State	Published - 10 Jun 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jacc.2008.03.017

Cite this

Choi, S. H., Prasad, A., & Tsimikas, S. (2008). The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology, 51(23), 2228-2229. https://doi.org/10.1016/j.jacc.2008.03.017

Choi, Seung Hyuk ; Prasad, Anand ; Tsimikas, Sotirios. / The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. In: Journal of the American College of Cardiology. 2008 ; Vol. 51, No. 23. pp. 2228-2229.

@article{99604637ffdf4098b569363134c2ece7,

title = "The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.",

author = "Choi, \{Seung Hyuk\} and Anand Prasad and Sotirios Tsimikas",

year = "2008",

month = jun,

day = "10",

doi = "10.1016/j.jacc.2008.03.017",

language = "English",

volume = "51",

pages = "2228--2229",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier Inc.",

number = "23",

}

Choi, SH, Prasad, A & Tsimikas, S 2008, 'The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.', Journal of the American College of Cardiology, vol. 51, no. 23, pp. 2228-2229. https://doi.org/10.1016/j.jacc.2008.03.017

The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. / Choi, Seung Hyuk; Prasad, Anand; Tsimikas, Sotirios.
In: Journal of the American College of Cardiology, Vol. 51, No. 23, 10.06.2008, p. 2228-2229.

Research output: Contribution to journal › Editorial

TY - JOUR

T1 - The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

AU - Choi, Seung Hyuk

AU - Prasad, Anand

AU - Tsimikas, Sotirios

PY - 2008/6/10

Y1 - 2008/6/10

UR - https://www.scopus.com/pages/publications/44449169081

U2 - 10.1016/j.jacc.2008.03.017

DO - 10.1016/j.jacc.2008.03.017

M3 - Editorial

C2 - 18534268

AN - SCOPUS:44449169081

SN - 0735-1097

VL - 51

SP - 2228

EP - 2229

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 23

ER -

Choi SH, Prasad A, Tsimikas S. The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology. 2008 Jun 10;51(23):2228-2229. doi: 10.1016/j.jacc.2008.03.017

The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

UN SDGs

Access to Document

Other files and links

Cite this

The Evolution of Thienopyridine Therapy. Clopidogrel Duration, Diabetes, and Drug-Eluting Stents^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.